Pembrolizumab more value in squamous cell carcinomas or adenocarcinomas Annual Meeting GI 2016

Dr. Toshihiko Doi, MD of National Cancer Center Hospital East, Japan discusses pembrolizumab and more value in squamous cell carcinomas or adenocarcinomas ASCO GI 2016